These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36814352)

  • 1. Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report.
    Albattat S; Alabdultaif A; Albattat F; Albattat B
    J Med Case Rep; 2023 Feb; 17(1):63. PubMed ID: 36814352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review.
    Villarreal-Martínez L; Sepúlveda-Orozco MDC; García-Viera DA; Robles-Sáenz DA; Bautista-Gómez AJ; Ortiz-Castillo M; González-Martínez G; Mares-Gil JE
    Blood Coagul Fibrinolysis; 2021 Sep; 32(6):418-422. PubMed ID: 33859115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
    Oldenburg J; Mahlangu JN; Kim B; Schmitt C; Callaghan MU; Young G; Santagostino E; Kruse-Jarres R; Negrier C; Kessler C; Valente N; Asikanius E; Levy GG; Windyga J; Shima M
    N Engl J Med; 2017 Aug; 377(9):809-818. PubMed ID: 28691557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
    Shimonishi N; Sasai K; Ogiwara K; Furukawa S; Nakajima Y; Mizumachi K; Yada K; Takeyama M; Shima M; Mizuno N; Nogami K
    Int J Hematol; 2023 Dec; 118(6):690-698. PubMed ID: 37803190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
    Mahlangu J; Oldenburg J; Paz-Priel I; Negrier C; Niggli M; Mancuso ME; Schmitt C; Jiménez-Yuste V; Kempton C; Dhalluin C; Callaghan MU; Bujan W; Shima M; Adamkewicz JI; Asikanius E; Levy GG; Kruse-Jarres R
    N Engl J Med; 2018 Aug; 379(9):811-822. PubMed ID: 30157389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of emicizumab in acquired hemophilia A: A case report.
    Yates SG; Webb CB; Sarode R; Ibrahim IF; Shen YP
    Transfus Apher Sci; 2022 Dec; 61(6):103457. PubMed ID: 35643753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy].
    Kageyama T; Mizuguchi M; Okamoto Y; Yagi H; Kagawa K; Shibata H; Ozaki S
    Rinsho Ketsueki; 2023; 64(3):198-202. PubMed ID: 37019673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.
    Shima M; Hanabusa H; Taki M; Matsushita T; Sato T; Fukutake K; Fukazawa N; Yoneyama K; Yoshida H; Nogami K
    N Engl J Med; 2016 May; 374(21):2044-53. PubMed ID: 27223146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Emicizumab in Acquired Factor VIII Deficiency.
    Hess KJ; Patel P; Joshi AM; Kotkiewicz A
    Am J Case Rep; 2020 May; 21():e922326. PubMed ID: 32376817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors.
    Kageyama Y; Matsumoto T; Tawara I; Wada H; Katayama N
    Am J Case Rep; 2019 Jul; 20():1022-1026. PubMed ID: 31303639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With Inhibitors.
    Watanabe AH; Lee SWH; Chai-Adisaksopha C; Lim MY; Chaiyakunapruk N
    Value Health Reg Issues; 2022 Mar; 28():7-13. PubMed ID: 34800834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage.
    Yamada Y; Nakajima Y; Ohara A; Wakita E; Shimizu K; Shimonishi N; Furukawa S; Ogiwara K; Takeyama M; Nogami K
    Int J Hematol; 2023 Apr; 117(4):607-612. PubMed ID: 36370317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
    Young G; Liesner R; Chang T; Sidonio R; Oldenburg J; Jiménez-Yuste V; Mahlangu J; Kruse-Jarres R; Wang M; Uguen M; Doral MY; Wright LY; Schmitt C; Levy GG; Shima M; Mancuso ME
    Blood; 2019 Dec; 134(24):2127-2138. PubMed ID: 31697801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spontaneous disappearance of the inhibitor during emicizumab therapy in a patient with mild hemophilia A].
    Matsumoto A; Ogawa Y; Uchiyama Y; Ishikawa T; Naito C; Kobayashi N; Miyazawa Y; Ishizaki T; Inoue M; Moteki Y; Kitazawa S; Murakami M; Matsumoto N; Handa H
    Rinsho Ketsueki; 2022; 63(10):1392-1396. PubMed ID: 36351645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emicizumab Prophylaxis in Patients with Severe Hemophilia A: Insights from A Resource Limited Country.
    Borhany M; Arshad A; Qureshi H; Nadeem R; Jamal A; Ahmed Khan R
    Clin Appl Thromb Hemost; 2024; 30():10760296231224357. PubMed ID: 38166474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile.
    Abarca-Villaseca V; Soto-Arellano V
    Am J Case Rep; 2021 Apr; 22():e929598. PubMed ID: 33883542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII.
    Jonsson F; Schmitt C; Petry C; Mercier F; Frey N; Retout S
    Clin Pharmacokinet; 2021 Jul; 60(7):931-941. PubMed ID: 33709296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
    Leissinger CA; Konkle BA; Antunes SV
    Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of bleeding in congenital hemophilia A patients with inhibitors.
    Teitel JM
    Transfus Apher Sci; 2018 Aug; 57(4):466-471. PubMed ID: 30093246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.